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Abstract
Using cDNA microarray analysis, we previously identified a set of differentially expressed genes in primary breast tumors based 
on the status of estrogen and progesterone receptors. In the present study, we performed an integrated computer-assisted and 
manual search of potential estrogen response element (ERE) binding sites in the promoter region of these genes to character-
ize their potential to be regulated by estrogen receptors (ER). Publicly available databases were used to annotate the position 
of these genes in the genome and to extract a 5’flanking region 2 kb upstream to 2 kb downstream of the transcription start 
site for transcription binding site analysis. The search for EREs and other binding sites was performed using several publicly 
available programs. Overall, approximately 40% of the genes analyzed were potentially able to be regulated by estrogen via 
ER. In addition, 17% of these genes are located very close to other genes organized in a head-to-head orientation with less 
than 1.0 kb between their transcript units, sharing a bidirectional promoter, and could be classified as bidirectional gene pairs. 
Using quantitative real-time PCR, we further investigated the effects of 17β-estradiol and antiestrogens on the expression of 
the bidirectional gene pairs in MCF-7 breast cancer cells. Our results showed that some of these gene pairs, such as TXNDC9/
EIF5B, GALNS/TRAPPC2L, and SERINC1/PKIB, are modulated by 17β-estradiol via ER in MCF-7 breast cancer cells. Here, 
we also characterize the promoter region of potential ER-regulated genes and provide new information on the transcriptional 
regulation of bidirectional gene pairs.
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Estrogens are crucial for the development and mainte-
nance of reproductive organs and play important roles in 
several target tissues, including bone and the cardiovascular 
and nervous systems. In the mammary gland, the estrogens 
mediate key physiological processes that are essential for 
normal growth, differentiation, and survival. A large body 
of evidence shows that estrogens, especially 17β-estradiol 
(E2), also play a pivotal role in promoting mammary carcino-
genesis (1). Most of the complex effects of estrogens on cell 
proliferation, differentiation, and survival are mediated by 
the estrogen receptors ERα and ERβ via the transcriptional 
regulation of ER target genes. In the classical mechanism of 
action, the estrogen receptor complex binds with high affin-
ity to estrogen response elements (EREs) in the promoter 
region of target genes, interacts with the basal transcription 
machinery, and regulates gene expression. The consensus 
ERE, which was first identified in the promoter region of 
the Xenopus vitellogenin gene, is a perfect palindromic 
DNA motif composed of two inverted sequences of 5 bp 
separated by three nucleotides: 5’-GGTCAnnnTGACC-3’ 
(2). Computational and experimental studies have revealed 
that most promoter regions in estrogen target genes in the 
human genome do not contain the consensus ERE, but 
contain degenerate palindromic sequences showing one 
or more substitutions, ERE half-sites, direct repeats of half-
palindromes, and other transcription factor binding sites, 
such as AP1, SP1, NF-κB, C/EBP, FoxA1, and octamers 
(2-5). ER also interacts with EREs containing variations in 
base substitution, although some nucleotide substitutions 
can be more harmful than others (6). Some symmetrical 
substitutions on each side of the palindrome may more dra-
matically affect the interaction with the ER than a unilateral 
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replacement (6). ERE half-site sequences associated with 
SP-1 sites, direct repeats of ERE half-sites, and EREs with 
different spacing between the palindromic sequences also 
display estrogen responses (7-9).
Genome-wide analysis has indicated that 10% of hu-
man genes are organized in a head-to-head orientation and 
located on opposite DNA strands in close proximity to the 
transcription start sites (TSS), separated from them by less 
than 1 kb (10,11). These genes are classified as bidirectional 
gene pairs and share an intervening sequence containing 
regulatory elements called bidirectional promoters (12,13). 
Bidirectional gene pairs are evolutionarily conserved, sug-
gesting that the close proximity might have been maintained 
for some functional reason (14). One possibility is that 
genes sharing promoters might be coordinately regulated 
in different tissues; however, the mechanisms underlying 
the transcriptional regulation of bidirectional promoters are 
still poorly understood (15,16). Much evidence indicates 
that bidirectional gene pairs might play a role in cancer; 
DNA repair genes that are involved in tumorigenesis are 
frequently found to be organized as bidirectional gene pairs 
(10,11). The expression profiles of ovarian and breast cancer 
show an enrichment of bidirectional gene pairs that include 
DNA repair genes, such as BRCA1, BRCA2, CKEK1, and 
FANC family members (17). Furthermore, the silencing 
of bidirectional gene pairs by DNA methylation has been 
reported in various human cancer cell lines and primary 
breast tumors (18-20).
In the present study, we performed an integrated 
computational and manual search to identify potential ER 
binding sites in the promoter region of 83 genes previously 
identified as being differentially expressed in primary breast 
tumors based on the presence of estrogen and proges-
terone receptors (21). We identified a subgroup of genes 
arranged in a head-to-head orientation and separated by 
a small intergenic region that could be classified as bidi-
rectional promoters. Selected candidate ER target genes 
were further examined for their potential to be modulated 
by 17β-estradiol in MCF-7 breast cancer cells.
Material and Methods
ERE binding site search 
The NCBI (http://www.ncbi.nlm.nih.gov), USCS Genome 
Bioinformatics (http://genome.uscs.edu) and ENSEMBL 
(http://www.ensembl.org) databases were used to anno-
tate the position of 83 genes in the genome and to extract 
sequences 2 kb upstream to 2 kb downstream of the TSS 
for binding site analysis. The search for EREs and other 
binding sites was performed using several publicly available 
programs (Transfac 6.0, http://www.gene-regulation.com, 
and Dragon Genome Explorer, http://research.i2.a-star.
edusg/promoter/). A list of ERE sequences was prepared 
from the reports extracted from PubMed and used for a 
manual search (6,22-24). The present study was approved 
by the Institutional Ethics Committee.
Cell lines and culture conditions 
Human breast cancer cells, MCF-7 and MDA-MB-231, 
were obtained from the American Type Culture Collection 
(ATCC). Cells were cultured at 37°C in phenol red-free RPMI 
supplemented with 10% FCS and 1% penicillin-streptomycin 
(Gibco, USA) in an atmosphere of 5% CO2/95% air. Be-
fore the treatments, cells were washed twice with PBS to 
remove residual serum and were grown in phenol red-free 
media containing 5% charcoal-stripped FCS for 48 h. After 
hormone deprivation, the cells were incubated with 10 nM 
17β-estradiol for 2, 6, and 24 h or treated with 1 µM 4-hy-
droxytamoxifen or 1 µM ICI 182.780 (Faslodex) alone or in 
combination with 17β-estradiol for 24 h. Cells maintained 
in phenol red-free media and supplemented with 5% FBS 
were used as controls. 
RNA extraction 
After the treatments, the cells were washed twice with 
PBS and harvested. Total RNA was extracted from cultured 
cells using the guanidine isothyocyanate method (25). RNA 
samples were analyzed using 1% agarose gel electropho-
resis and ethidium bromide staining. The quality of the RNA 
samples was estimated by the ratio of 28S:18S (2.0 and 
higher). All RNA samples were treated with DNaseI for 1 h 
at 37°C to eliminate genomic DNA contamination.
Quantitative real-time PCR (qPCR) 
qPCR was performed using the GeneAmp 7500 Se-
quence Detection System (Applied Biosystems, USA). cDNA 
was generated using the High Capacity cDNA Archive kit 
(Applied Biosystems), and each cDNA sample was analyzed 
in duplicate. PCR was carried out in a total volume of 50 
µL according to manufacturer instructions for SYBR Green 
PCR Core reagent (PE Applied Biosystems). Primer pairs 
were designed using the Primer3 software (http://frodo.
wi.mit.edu/primer3/). The primers used for qPCR analy-
sis were as follows: DIDO1, 5’-AGAAAGCTGCAAATCC 
AAGTG-3’ and 5’-GGCGTGTTTGAGGATACAGTC-3’; 
C20orf11, 5’-TTTGACAGTCCCGAGGAGTC-3’ and 
5’-GTGTTGACTCGCGATTTTCAT-3’; TXNDC9, 5’-GTG 
AAAATGTGGTTTGCCATT-3’ and 5’-TGCTTTTTCCACATT 
CAGCTT-3’; EIF5B, 5’-AGATTCGAGGCCTCCTGTTAC-3’ 
and 5’-GGGTAAACCAGCCAATGTTTT-3’; GALNS, 
5’-CAGGATCACCTCGGTCGT-3’ and 5’-GAATGGATTCTG 
GAGGTGTCA-3’; TRAPPC2L, 5’-GTCACCAACTCCAA 
GGTGAAG-3’ and 5’-TTGTAGAAGGGGTTGCACATC-3’; 
SERINC1, 5’-GTGATGGATCACTGGAGGATG-3’ and 
5’-TCACGAGAGGGTTCATACCTG-3’; PKIB, 5’-CGG 
AATGCCTTACCAGACATC-3’ and 5’-TTCTTCATTTTG 
AGGCTTTTCC-3’; GTPBP2, 5’-CCTACACACCACCAT 
CTTTGG-3’ and 5’-ATGAAGAAGGGCACTTTCAGG-3’; 
MAD2L1BP, 5’-GCAGAGGAGATGCTGAAGAAG-3’ and 
5’-GGCTGAGGACACTCTCCAGTT-3’; GAPDH, 5’-CCTCC 
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AAAATCAAGTGGGGCG-3’ and 5’-GGGGCAGAGATG 
ATGACCCTT-3’.
The relative gene expression was normalized using 
GAPDH expression as an internal control. MCF-7 cells main-
tained in phenol red-free medium and supplemented with 
5% FCS served as calibrator samples for hormone-treated 
cells. The results are reported as n-fold differences in the 
expression of the target gene relative to the expression of 
GAPDH and a calibrator sample. The relative expression 
was calculated by 2-∆∆CT, where CT is the fluorescence 
threshold value, ∆CT = CT of the target gene - CT of the 
reference gene, and ∆∆CT = ∆CT of the tumor sample - ∆CT 
of the calibrator sample. 
Statistical analysis 
Statistical analyses were performed by one-way ANOVA 
using the SPSS 10.0 software (Statistical Package for the 
Social Sciences; SPSS Inc., USA), and P values were 
calculated using the Bonferroni test and considered to be 
significant at P < 0.05.
Results
In a previous study using cDNA microarray, we iden-
tified differentially expressed transcripts between ER/
progesterone receptor (PR)-positive and ER/PR-negative 
primary breast tumors, providing a new set of potential 
target genes for the ER signaling pathway. In the present 
study, in order to identify DNA binding sites that mediate 
the estrogen response, we performed a computer-assisted 
and manual search for putative ERE binding sites in the 
promoter region extracted from 83 of these 
potential ER target genes. The manual 
search was performed using a list of putative 
ERE binding sites based on data available 
in the literature. A summary of the results 
obtained from this analysis is shown in Fig-
ure 1. Overall, 43% (36/83) of the candidate 
genes showed a good potential for being 
regulated by estrogen via ER. The promoter 
regions of these genes contain perfect or 
imperfect palindromic sequences, SP1, 
AP1, and/or FOXA1 binding sites. 
Interestingly, during the annotation of 
the 83 potential ER target genes, we iden-
tified 17 genes located in close proximity 
to other genes and organized in a head-
to-head orientation, possibly sharing the 
same promoter region. Using criteria of an 
intergenic distance of <1000 bp spanning 
the TSS of the divergent gene pair to define 
bidirectional promoters (11), we identified 
14 (16.8%) bidirectional gene pairs (Table 
1). The size of the intergenic sequences 
ranged from 18 to 973 bp, and all of these 
bidirectional promoters contain CpG-rich sequences. 
Figure 2 shows a schematic representation of three of the 
bidirectional gene pairs identified. We also investigated 
whether the identified bidirectional gene pairs maintained 
their divergent head-to-head organization in other species. 
Although limited, our analysis showed that the majority of the 
bidirectional gene pairs found in this study is evolutionarily 
conserved, as shown in Figure 3 for the GALNS/TRAPPC2L 
divergent gene pair.
Our computer-assisted search for EREs revealed that 
the promoter regions of the majority of the bidirectional gene 
pairs showed good potential to be regulated by estrogen. 
As shown in Table 1, all 14 bidirectional promoters analyzed 
contain putative ERE binding sites (at least half EREs) and 
other binding sites for other transcription factors, such as 
SP1 and AP1 or FOXA1 binding sites, indicating that they 
have the potential to be regulated by ER. The putative EREs 
were also found to be conserved in different species (Figure 
3). In addition, approximately 80% of these bidirectional 
promoters contain GABP binding sites (CCGGAA(GTG)). 
We further evaluated the expression of five of these bidi-
rectional gene pairs in response to 17β-estradiol in MCF-7 
breast cancer cells. The gene pairs GALNS/TRAPPC2L, 
TXNDC9/EIF5B, and SERINC1/PKIB were modulated by 
estradiol (Figure 4). However, the expression of the gene 
pairs GTPBP2/MAD2L1BP and DIDO1/C20orf11 was 
not affected in the MCF-7 cells exposed to 17β-estradiol 
or to the antiestrogens tamoxifen and ICI 182,780 (data 
not shown). The transcripts of GALNS and TRAPPC2L 
showed increased expression in MCF-7 cells maintained 
in stripped serum (deprived of steroids and growth 
Figure 1. Summary of the results of the estrogen response element (ERE) search 
for 83 potential estrogen receptor target genes. The NCBI (http://www.ncbi.nlm.
nih.gov) and USCU Genome Bioinformatics (http://www.genome.uscs.edu) data-
bases were used to annotate the position of the 83 differentially expressed genes 
in the genome and to extract sequences 2 kb upstream and 2 kb downstream 
of the start sites for binding site analyses. The search for EREs and other bind-
ing sites was performed using several publicly available programs (Transfac 6.0, 
http://www.gene-regulation.com, and Dragon Genome Explorer, http://research.
i2.a-star.edusg/promoter/). 1Palindromic ERE consensus derived from vitellogenin 
A2 (GGTCAnnnTGACC) separated by 1 to 7 bp. 2Imperfect palindromic ERE car-
rying a single substitution. 3Imperfect palindromic ERE carrying two substitutions. 
4Direct repeats separated by 3 bp. 
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Table 1. List of the bidirectional gene pairs identified. 
Annotated gene Bidirectional 
partner
Chromosome 
localization
ERE position*   ERE sequences Intergenic 
distance (bp)
C16orf61 CENPN 16q23.2 -1158 to -1141 CGGGTCACTGCAACCTC 236
-664 to -648 CTGGTCACATGACCAC
+484 to +501 CCGGTAAAATGGACCTT
+1663 to +1681 TTGGCCAGGCTTGTCCTG
+775 to +783 FOXA1
-1345 to -1338 GABP
DIDO1 C20orf11 20q13.33 -1131 to -1110 CTCGACCTCCTGGGCTCAAG 166
-532 to -515 ACTGCCCCCTGGGCACC
+193 to +211 AGTGTCCCTGAGGTCCAG
-55 to -46 GABP
GALNS TRAPPC2L 16q24.3 -1952 to 1934 TAGGTCCTCCCTGACACA 119
-1452 to -1432 CTGGGCACGCCTCTCACCTT
-1116 to -1099 ATGATCATCTTGGCCAA
-865 to -846 GAGGGCAGAGCATGTCCAG
-221 to -242 CGTGACCCGCCGCTGGTCACG
-168 to -148 CTGGTCACGAGGCAGTCCAG
-107 to -91 CGAGTCACGTGGCCGT
-44 to -24 TAGGTCGGCTCGCTGGCCGG
+361 to +379 GCGGTCACCGATCACCAC
+668 to +684 AAGGTCAGGTGTCCCT
+732 to +748 GGGGTCAGGGGTCACA
+816 to +834 TGGGGCATGGGTCACCGT
+923 to +941 GGGGTTACACCTGTCCCG
-68 to -61 GABP
GTPBP2 MAD2L1BP 6p21-p12 -1100 to -1084 CAGGTCCCGGGACCCC 342
-1057 to -1041 CAGGTGACAGGACCTC
-422 to -404 CCTGACCTCAGGTGATC
-264 to -248 GCTGGTCCCAGGACCTC
+1057 to +1076 TTGGTCAGGCTGGTCTC
+1080 to +1099 GCTGACCTCTGGTGATC
-1096 to -1089 GABP
HNRPK RMI1 9q21.32 -1800 to -1782 CCTGACCTTGTGGTCCGC  67
+328 to +345 CGTGGCCTCGGGCCAAT
+881 to +899 ACGGTCAGGGCTGCCTCG
-1729 to -1720 GABP
KARS TERF2IP 16q23-q24 -930 to 910 GCGCTCAGCCTCCTCACCCC 243
-188 to -172 GAGCTCAACTGACTGA
+1566 to 1586 CTTGACTTTATTAAGTCAAA
-1551 to -1543 FOXA1
-82 to -72 GABP
LRRC49 THAP10 15q23 -1824 to -1807 AAGGTCAGCATGATGGT 233
-1793 to -1778 AGGGACAGTGGCCTT
-553 to -523 GTGGTCAGAGCGATGACCGAG 
CGGTCATT
-252 to -235   CCCTACCTCTGGTCACC
-262 to -252   FOXA1
Continued on next page
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Annotated gene Bidirectional 
partner
Chromosome 
localization
ERE position* ERE sequences Intergenic 
distance (bp)
-237 to -228 GABP
-84 to -75
MRPL27 EME1 17q21.3-q22 -1312 to -1296 AGGATCACTTGAGCCC  18
-321 to -300 GGGGGCCTCATCTCTGACCCT
+109 to +126 GAGGTGACACTGATCCC
+189 to +205 CTGGTCACGTGACACA
+816 to +832 AGGATCACCTGAGCTC
+957 to +977 AGGGACAGGAGAGTGACTTG
+1748 to +1767 TGGGTCATGGTTGGACCTC
+1273 to +1265 FOXA1
-22 to -13 GABP
SERINC1 PKIB 6q22.31 -1166 to -1149 CCTGGCCTTGTGACCCG 109
-1323 to -1306 CGGCTCACTGCAACCTC
+674 to +690 CATGCCTTGTGCCTAA
+1534 to +1556 GGGGTCTAAGTGTATTGGCCGG
-78 to 68 FOXA1
-96 to -87 GABP
SLC5A6 C2orf28 2p23 Half EREs 320 
SP1 sites
TCF19 CCHR1 6q21.3 -2052 to -2032 CCTGGCCAGAGGTGAGA 736
-1939 to -1920 CATGACTCTTGGGTCCTT
+198 to +216 GATGACTGGAGGGTCAGC
+250 to +268 CAGGGCAGCTTTGCCCCT
+439 to +457 TAGCTCATACAGGACCTG
TMEM186 PMM2 16p13.13 -1519 to -1501 GTGGTTACTATAGACCAC 268
-1289 to -1267 AAGGTCACACGCATTTGACCTG
-1166 to -1144 ATGGCCAGTGTTCAGTGGCCAA
-1134 to -1112 GGGGCCAGGAGAGCCTCACCTC
-1022 to -1000 GCGGGCAGCCTGTAATAACCTA
-791 to -771 AAGGTCACACAGATGTCAAG
-751 to -734 TAGGTCGGTTTGACCTG
+1129 to +1148 GTGGGCAGCAGTTCACCCA
+1474 to +1493 CAGGACACATACTGTCCCA
+1884 to +1903 TCAGTCAGATAATGGCCAG
-29 to -21 FOXA1
-215 GABP
TXNDC9 EIF5B* 2q11.2 -1958 to -1943 TAGGACTGTGACCCT 973
-717 to -698 TAGGTCCCCTCTTGACTCT
-660 to -640 AGGGTGAAGCTGAAGACCTA
-560 to -540 GAGGTCCCTATTTTGTCCTG
+338 to +354 CGTGGCCCAGGCCAGT
+1660 to +1679 TTGGTCAGGCTGGTCTC
-1095 to -1089 GABP sites
+609 to +616
Table 1 continued
Continued on next page
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Figure 2. Schematic presentation of the bidirectional gene pairs GALNS/TRAPPC2L, TXNDC9/
EIF5B, and SERINC1/PKIB. The transcriptional units of the bidirectional gene pairs are organized 
in a head-to-head orientation on chromosomes 16q24.3 (GALNS/TRAPPC2L), 2q11.2 (TXNDC9/
EIF5B), and 16q24.3 (SERINC1/PKIB) (http://genome.uscs.edu). The transcript start site (TSS) 
for each gene is indicated by black arrows, which show the transcriptional direction. Open boxes 
indicate the first exons of each gene. Black boxes indicate intergenic sequences for each gene 
pair. The boxes with vertical bars represent CpG-rich sequences.
Annotated gene Bidirectional 
partner
Chromosome 
localization
ERE position* ERE sequences Intergenic 
distance (bp)
NPC2 ISCA2 14q24.3 -1745 to -1729 AGAGTCACCAGTCATC 500
-564 to -545 TCGGCCAGGGAGTGACCGC
-106 to -89 CAGGTCGCCTGACTGG
+33 to +54 GCGCTCAGCACCGCTGCCCAG
+182 to +199 GCGGCCAGGCTGAGCCT
+1531 to +1549 TAGGTGAGTCCTGATCTC
-159 to -151 GABP
Half-estrogen response elements (half-EREs) are listed in bold and underlined. *Numbers refer to the location of the EREs listed rela-
tive to the transcription start site of the annotated gene.
Table 1 continued
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Figure 3. Evolutionarily conserved estrogen receptor binding elements (EREs) in the potential promoter region of the bidi-
rectional gene pair GALNS/TRAPPC2L across vertebrates. A, Schematic presentation of the bidirectional gene pair GALNS/
TRAPPC2L in humans, chimpanzees, dogs, rats, and chickens. The black arrows and numbers 1 to 5 indicate the location of 
conserved EREs relative to the position of the transcript start site in the TRAPPC2L gene. B, 1 to 5 ERE sequences; EREs 2 
(C) and 5 (D) and the surrounding sequences are shown in the alignment. The half-EREs are in bold. Asterisks denote highly 
conserved bases.
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antiestrogens are able to modulate the transcripts of GALNS/
TRAPPC2L, TXNDC9/EIF5B, and SERINC1/PKIB in ER-
Figure 4. Effects of 17β-estradiol (E2) and the anti-estrogens tamoxifen (T) and 
ICI 182,780 (ICI), on the transcriptional regulation of the bidirectional gene pairs 
GALNS/TRAPPC2L (A), TXNDC9/EIF5B (B), and SERINC1/PKIB (C) in MCF-
7 breast cancer cells. Synchronized MCF-7 cells were cultured in: NS, medium 
supplemented with 5% fetal calf serum (FCS); SS, medium supplemented with 5% 
charcoal-stripped FCS; E2 - 2 h, exposed to E2 (10 nM) for 2 h; E2 - 6 h, exposed 
to 10 nM E2 for 6 h; E2 - 24 h, exposed to 10 nM E2 for 24 h; T - 24 h, exposed to 
1 μM tamoxifen for 24 h; T+E2 - 24 h, exposed to 1 μM tamoxifen plus 100 nM E2 
for 24 h; ICI - 24 h, exposed to ICI 182,780 for 24 h, or ICI+E2 - 24 h, exposed to 
ICI 182,780 plus E2 (100 nM) for 24 h. Data are reported as means ± SD of three 
experiments. *P < 0.05 compared to NS and/or SS (one-way ANOVA followed by 
the Bonferroni post-test).
factors) compared to the cells grown in normal serum (con-
trol cells) and were negatively modulated in the presence of 
10 nM 17β-estradiol for 24 h (Figure 4A). A 
similar reduction in these transcripts was 
observed in MCF-7 cells treated with 1 μM 
tamoxifen or 1 μM tamoxifen plus 100 nM 
17β-estradiol compared to the expression 
in MCF-7 cells maintained in stripped 
serum. However, in MCF-7 cells treated 
with 1 μM ICI 182,780 alone the GALNS/
TRAPPC2L transcripts showed increased 
expression compared to control cells and 
remained elevated in cells treated with 1 
μM ICI 182,780 plus 100 nM 17β-estradiol. 
The transcripts of the bidirectional gene 
pair TXNDC9 and EIF5B were positively 
regulated by 10 nM 17β-estradiol after 6 
h of treatment (Figure 4B). In contrast to 
the gene pair GALNS/TRAPPC2L, the 
TXNDC9 and EIF5B transcripts were not 
significantly altered in MCF-7 cells grown 
in stripped serum compared to control 
cells, but both transcripts were significantly 
induced (>2-fold) in MCF-7 cells exposed 
to 10 nM 17β-estradiol for 6 h. After 24 h 
of 17β-estradiol treatment, the expression 
of these transcripts was similar to that 
observed in control cells. However, the 
transcripts of the TXNDC9 and EIF5B 
gene pair were not affected by treatment 
with the antiestrogens tamoxifen and ICI 
182,780 alone or in combination with 
17β-estradiol for 24 h compared to cells 
growing in normal or stripped serum. Inter-
estingly, the transcripts of the bidirectional 
gene pair SERINC1/PKIB were divergently 
modulated by 17β-estradiol (Figure 4C). 
Expression of the PKIB transcripts was 
reduced in MCF-7 cells maintained in 
stripped serum and was substantially 
stimulated by 10 nM 17β-estradiol after 
6 h of treatment, whereas the SERINC1 
transcripts increased in MCF-7 cells grown 
in stripped serum and expression was 
significantly inhibited in the presence of 
17β-estradiol. In addition, cells treated 
with 1 μM tamoxifen showed a reduction of 
protein kinase inhibitor beta (PKIB) levels, 
which was reversed in the presence of 
100 nM 17β-estradiol. Treatment with ICI 
182,780 dramatically reduced the expres-
sion of PKIB but did not affect the expres-
sion of SERINC1 transcripts compared to 
cells grown in stripped serum.
To determine whether 17β-estradiol or 
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negative breast cancer cells, MDA-MD-231 cells was also 
treated with 17β-estradiol and/or antiestrogens for 6 and 
24 h. Estrogen or antiestrogens were unable to regulate 
the transcripts of these bidirectional gene pairs (data not 
shown) in MDA-MB-231 cells.
Discussion
In the present study, we employed an integrated com-
puter-assisted and manual search to identify EREs in the 
promoter region of a set of candidate ER target genes previ-
ously identified as being differentially expressed in primary 
breast tumors based on their estrogen and progesterone 
status (21). Using this approach, we characterized the pro-
moter region of 83 genes for their potential to be regulated 
by ER. Although only a small percentage of the candidate 
ER target genes showed the presence of an ERE consensus 
sequence in their promoter region, more than 40% of these 
genes were found to have putative ERE, SP1, AP1, and/or 
FOXA1 binding sites in their promoter regions, indicating 
the potential to be regulated by estrogen. The maximum 
ER transcriptional transactivation is thought to be displayed 
by the interaction of a homo- or heterodimer of ER with the 
ERE consensus sequence (CAGGTCAnnnTGACCTG). 
However, the ERE consensus sequence is rarely found in 
the promoter regions of human genes (2). The promoter 
regions of estrogen-responsive genes usually contain more 
than one imperfect palindromic sequence separated by one, 
two, three, or more interstitial bases, direct repeats of ERE 
half-sites, and widespread ERE half-sites (2). Half-EREs 
have been shown to act synergistically, but the degree 
of synergy between EREs is modulated by the physical 
distance between EREs and by the distance between the 
ERE and the TATA-box (26). In addition, perfect or imper-
fect ERE half-sites adjacent to AP1 or SP1 binding sites in 
the promoter region of known estrogen-regulated genes, 
such as HSP27 and PR, were also found to be effective in 
conferring estrogen responsiveness (27,28).
During the process of gene annotation, we identified a 
subgroup of divergent gene pairs organized in a head-to-
head orientation that could be classified as bidirectional 
gene pairs. Surprisingly, the prevalence of bidirectional 
gene pairs found in the set of candidate ER target genes 
analyzed was higher than the predicted frequency of 
9.4-11% found in the human genome by computational 
genome-wide studies (11,29). An incremental prevalence 
of gene pairs organized in a head-to-head orientation has 
also been observed among the genes that encode proteins 
that function in DNA repair (10,17). 
Bidirectional gene pairs show evolutionary conserva-
tion, which suggests a selective pressure to facilitate the 
expression of functionally related genes or those that need 
to be co-regulated by the same stimulus or in a cell-specific 
manner (10,11,29). In agreement with the literature, the 
majority of the bidirectional gene pairs identified in the 
present study were shown to be conserved during evolu-
tion, keeping the same organization in vertebrates and 
indicating that these genes organized in a head-to-head 
orientation play important roles (29,30). Our data also 
showed that some of the putative ERE binding sites were 
conserved in the bidirectional gene pairs in other species. 
Different degrees of conservation of ERE or ERE-SP1 sites 
have been reported in the literature (4,9,31). In addition, 
the majority of the bidirectional promoters analyzed also 
contain GABP binding sites, which were previously shown 
to be over-represented in bidirectional promoters (32,33). 
However, whether or not they are all likely to be functionally 
conserved is still being questioned.
The bidirectional head-to-head orientation suggests that 
the potential promoter regions of these gene pairs share 
cis-elements, such as ERE and SP1 sites, that could be tran-
scriptionally regulated by estrogen. To validate our results, 
we evaluated the effects of estrogen and antiestrogens on 
the transcriptional regulation of five bidirectional gene pairs 
in the breast cancer cell line MCF-7. To our surprise, the 
expression of two of the bidirectional gene pairs, GTPBP2/
MAD2L1BP and DIDO1/C20orf11, was not modulated in 
MCF-7 cells exposed to estrogen and antiestrogens. Since 
the activity of transcription factors in transcriptional trans-
activation depends on the state of the chromatin (34,35), 
we can speculate that, in MCF-7 cells, the E2-ER complex 
has no accessibility to the binding sites in the promoter 
regions of these genes, possibly due to the state of chro-
matin organization. Further studies using different cell lines 
and agents that affect chromatin organization are required. 
On the other hand, distinct patterns of gene regulation by 
estrogen and antiestrogens were observed for the bidirec-
tional gene pairs GALNS/TRAPPC2L, TXNDC9/EIF5B, and 
SERINC1/PKIB in MCF-7 cells. In contrast, in ER-negative 
breast cancer cells, MDA-MB-231, 17β-estradiol or anti-
estrogens (tamoxifen or ICI) were unable to modulate the 
mRNA expression of these bidirectional gene pairs (data 
not shown), indicating that the presence of ER is essential 
for the transcriptional transactivation of these bidirectional 
promoters by estrogen. In MCF-7 cells, two of the gene 
pairs analyzed displayed a positive correlation, with both 
gene transcripts being up-regulated (TXNDC9/EIFB5) or 
down-regulated (GALNS/TRAPPC2L) by estrogen. The 
differences observed in the effects of the antiestrogens 
tamoxifen and ICI 182,780 on the transcriptional regulation 
of these bidirectional gene pairs can be attributed to their 
mechanisms of action. Tamoxifen is a selective estrogen 
modulator that acts by inhibiting estrogen binding to its 
main target estrogen receptor; however, it also acts as an 
estrogen agonist in certain tissues or in specific regulation 
of ER-responsive genes (36). Compared to tamoxifen, ICI 
182,780 is considered to be a pure antagonist that blocks 
ER-mediated transactivation down-regulating ER protein 
levels. Additionally, the gene pair SERINC1/PKIB showed 
a negative correlation with the up-regulation of PKIB tran-
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